First identified in 2012, the MERS-coronavirus is capable of causing severe pneumonia. There are no effective treatments for MERS. Researchers have now identified a cellular recycling process known as autophagy as a potential target in the fight against MERS. Autophagy-inducing substances – including licensed drugs – were shown to be capable of reducing the viral replication rate.